Inter Pharma PCL (BKK:IP)

Market Cap	2.77B
Revenue (ttm)	2.17B
Net Income (ttm)	111.34M
Shares Out	605.34M
EPS (ttm)	0.18
PE Ratio	24.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	307,206
Average Volume	582,087
Open	4.600
Previous Close	4.600
Day's Range	4.560 - 4.700
52-Week Range	2.020 - 4.700
Beta	0.57
RSI	76.66
Earnings Date	Feb 27, 2026

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 64
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.